News & Updates
Filter by Specialty:
Histotripsy 2.0 available for liver and breast cancer clinical trials in HK
Asia’s first histotripsy 2.0 system, introduced at the Chinese University Hong Kong (CUHK) recently, will be used in clinical trials to treat liver cancer patients from early 2025. The novel focal therapy will also be evaluated in patients with early-stage breast cancer.
Histotripsy 2.0 available for liver and breast cancer clinical trials in HK
05 Dec 2024
Crowding, mobility predict TB infection among kids
A high prevalence of tuberculosis (TB) infection is seen among children and adolescents residing in rural Uganda, a study has found. Crowding and mobility are some of the factors associated with TB risk.
Crowding, mobility predict TB infection among kids
04 Dec 2024
Fezolinetant eases symptoms in menopausal women unfit for hormone therapy
Use of fezolinetant demonstrates efficacy and good tolerability in the treatment of moderate-to-severe vasomotor symptoms associated with menopause in women who are deemed unsuitable for hormone therapy, reports a study.
Fezolinetant eases symptoms in menopausal women unfit for hormone therapy
04 Dec 2024
Low BMD predicts death, infections in stroke patients
Stroke patients who have low bone mineral density (BMD), particularly in the spine and femur, are at greater risk of mortality and urinary tract infection (UTI), reveals a study.
Low BMD predicts death, infections in stroke patients
04 Dec 2024
Pooled analysis ASSUREs seladelpar role in PBC
Results of the phase III ASSURE study support seladelpar – a novel first-in-class delpar (selective peroxisome proliferator-activated receptor delta agonist) – for the treatment of primary biliary cholangitis (PBC).